Investigation of the efficacy of inflawell syrup on covid-19 patients : Evaluation of the effect of inflawell-syrup on the immune response and the signaling pathway of NF-kB in peripheral blood mononuclear cell in patients with COVID-19: Double blind, placebo-controlled randomized clinical trial

Medienart:

Klinische Studie

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

WHO International Clinical Trials Registry Platform - (2021) vom: 21. Juni Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: COVID-19. Coronavirus infection, unspecified;B34.2
Recruitment Status: Completed
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2021-03-14, Last updated: 2022-11-24

ICTRP ID:

IRCT20170315033086N10

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007609051